GSK announced on Tuesday that a single dose of its Arexvy vaccine against respiratory syncytial virus (RSV) was 43.3% ...

In another blow to its $525 million buyout of ReViral, Pfizer has ended development of sisunatovir, an oral inhibitor ...

Former executives of the pharmaceutical giant are backing a push by activist investor Starboard Value to turn aro ...

Pfizer chief executive Albert Bourla plans to meet Starboard Value, said people familiar with the matter, as the activist investor’s $1bn stake in the pharmaceutical group puts pressure on its board ...

Pfizer CEO Albert Bourla plans to meet activist investor Starboard Value, the Financial Times reported on Tuesday, citing ...

Over the summer, the Biomedical Emerging Technology Applications (BETA) Summer Fellows Industry Program provided six ...

Pfizer (PFE) discontinues development of experimental RSV therapy sisunatovir from pipeline in a blow for its $525M ...

Is your company bracing for Milton or working to provide aid in anticipation of the storm? | Pfizer—which opened a global hub ...

The Roundhill Magnificent Seven ETF — which holds Big Tech stocks including Nvidia, Apple Inc., Microsoft Corp, Alphabet Inc.

Pfizer Inc.’s stock gained Monday after a report that activist investor Starboard Value has invested $1 billion in the drug ...

Roivant Sciences Ltd. (NASDAQ:ROIV)’s management shared key details for IMVT-1402 during the Q1 2025 earnings call: ...

More than 200 brands spoke out in the week that followed Hamas’ terrorist attacks against Israel a year ago. Yet companies ...